| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Mei-Chin Yin | |
| P2860 | cites work | Corosolic acid prevents oxidative stress, inflammation and hypertension in SHR/NDmcr-cp rats, a model of metabolic syndrome | Q80227858 |
| Nonenzymatic antioxidative and antiglycative effects of oleanolic acid and ursolic acid | Q80689535 | ||
| Contribution of polyol pathway to arteriolar dysfunction in hyperglycemia. Role of oxidative stress, reduced NO, and enhanced PGH(2)/TXA(2) mediation | Q81302979 | ||
| Glucagon-like peptide-1 (GLP-1) inhibits advanced glycation end product (AGE)-induced up-regulation of VCAM-1 mRNA levels in endothelial cells by suppressing AGE receptor (RAGE) expression | Q82306139 | ||
| Advanced glycation end products strongly activate platelets | Q84295860 | ||
| Protection of glycyrrhizic acid against AGEs-induced endothelial dysfunction through inhibiting RAGE/NF-κB pathway activation in human umbilical vein endothelial cells | Q86488833 | ||
| Antibacterial and antioxidant activities of ursolic acid and derivatives | Q87144219 | ||
| RAGE: a potential target for Abeta-mediated cellular perturbation in Alzheimer's disease | Q95823643 | ||
| Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis | Q24564718 | ||
| Does accumulation of advanced glycation end products contribute to the aging phenotype? | Q24632710 | ||
| Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging | Q24650528 | ||
| Terpenoid metabolism | Q24674090 | ||
| The broad anti-viral agent glycyrrhizin directly modulates the fluidity of plasma membrane and HIV-1 envelope | Q27472782 | ||
| Pentacyclic triterpenes of the lupane, oleanane and ursane group as tools in cancer therapy | Q28258059 | ||
| AGEs increased migration and inflammatory responses of adventitial fibroblasts via RAGE, MAPK and NF-kappaB pathways | Q28574020 | ||
| Aldose reductase and the role of the polyol pathway in diabetic nephropathy | Q28645739 | ||
| On the origins of triterpenoid skeletal diversity | Q29014385 | ||
| Neuronal and glial advanced glycation end product [Nepsilon-(carboxymethyl)lysine]] in Alzheimer's disease brains | Q31980468 | ||
| RAGE signaling in inflammation and arterial aging | Q33346824 | ||
| Mechanisms of cell signaling in immune-mediated inflammation. | Q33539144 | ||
| The biology of the receptor for advanced glycation end products and its ligands | Q34100112 | ||
| MCP-1 and RANTES are mediators of acute and chronic inflammation | Q34292601 | ||
| Botanicals in cardiovascular health | Q34401182 | ||
| Advanced glycoxidation end products in commonly consumed foods | Q34549688 | ||
| Protective effect of taraxasterol against LPS-induced endotoxic shock by modulating inflammatory responses in mice | Q34657934 | ||
| Receptor for Advanced Glycation Endproducts (RAGE): a formidable force in the pathogenesis of the cardiovascular complications of diabetes & aging | Q34760415 | ||
| The interleukin-8 pathway in cancer. | Q34871322 | ||
| Anti-inflammaging and antiglycation activity of a novel botanical ingredient from African biodiversity (Centevita™). | Q35077463 | ||
| Involvement of Maillard reactions in Alzheimer disease | Q35164047 | ||
| Polyol pathway in the pathogenesis of diabetic complications and aldose reductase inhibitors | Q35223881 | ||
| Nitric oxide, oxidative stress, and progression of chronic renal failure | Q35836022 | ||
| Diet-derived advanced glycation end products are major contributors to the body's AGE pool and induce inflammation in healthy subjects | Q36203944 | ||
| Advanced glycoxidation end products in chronic diseases-clinical chemistry and genetic background. | Q36220722 | ||
| Overproduction of reactive oxygen species in end-stage renal disease patients: a potential component of hemodialysis-associated inflammation | Q36271080 | ||
| TAGE (toxic AGEs) theory in diabetic complications | Q36483059 | ||
| Methylglyoxal in food and living organisms. | Q36653426 | ||
| Redox regulation of cellular stress response in neurodegenerative disorders | Q36726634 | ||
| Forty years of furosine - forty years of using Maillard reaction products as indicators of the nutritional quality of foods | Q36772581 | ||
| The biology of RAGE and its ligands: uncovering mechanisms at the heart of diabetes and its complications | Q36787569 | ||
| Pathobiology of transforming growth factor beta in cancer, fibrosis and immunologic disease, and therapeutic considerations | Q36921222 | ||
| The clinical relevance of assessing advanced glycation endproducts accumulation in diabetes | Q36942530 | ||
| Diagnostic utility of serum or cerebrospinal fluid levels of toxic advanced glycation end-products (TAGE) in early detection of Alzheimer's disease | Q36948811 | ||
| Redox regulation of lung inflammation: role of NADPH oxidase and NF-kappaB signalling. | Q36979666 | ||
| Reactive oxygen species: current knowledge and applications in cancer research and therapeutic | Q37049206 | ||
| Cellular signaling and potential new treatment targets in diabetic retinopathy | Q37089750 | ||
| RAGE: a single receptor for several ligands and different cellular responses: the case of certain S100 proteins. | Q37106500 | ||
| Role of advanced glycation end products (AGEs) and oxidative stress in diabetic retinopathy | Q37160899 | ||
| The role of AGEs in cardiovascular disease | Q37160911 | ||
| Aging and glycoxidant stress | Q37162775 | ||
| Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging. | Q37363088 | ||
| CNS drug delivery systems: novel approaches | Q37370754 | ||
| Role of oxidative and nitrosative stress biomarkers in chronic heart failure. | Q37410271 | ||
| RAGE and Alzheimer's disease: a progression factor for amyloid-beta-induced cellular perturbation? | Q37455857 | ||
| Hyperglycemia and glycation in diabetic complications. | Q37505050 | ||
| Oxidative stress and mitochondrial dysfunction in atherosclerosis: mitochondria-targeted antioxidants as potential therapy. | Q37630642 | ||
| The complexes of drugs with carbohydrate-containing plant metabolites as pharmacologically promising agents | Q37636227 | ||
| Advanced glycation end products and receptor-oxidative stress system in diabetic vascular complications | Q37642895 | ||
| The molecular biology of senile plaques and neurofibrillary tangles in Alzheimer's disease. | Q37669870 | ||
| Transporters in the brain endothelial barrier. | Q37696513 | ||
| RAGE and the pathogenesis of chronic kidney disease | Q37737557 | ||
| 18β-Glycyrrhetinic acid inhibits adipogenic differentiation and stimulates lipolysis | Q38463969 | ||
| Advanced glycation end products increases matrix metalloproteinase-1, -3, and -13, and TNF-alpha in human osteoarthritic chondrocytes | Q38506314 | ||
| Maslinic acid induces mitochondrial apoptosis and suppresses HIF-1α expression in A549 lung cancer cells under normoxic and hypoxic conditions. | Q38933675 | ||
| Suppression of hepatitis B virus x protein-mediated tumorigenic effects by ursolic Acid | Q39594056 | ||
| Betulin and betulinic acid attenuate ethanol-induced liver stellate cell activation by inhibiting reactive oxygen species (ROS), cytokine (TNF-α, TGF-β) production and by influencing intracellular signaling | Q39617873 | ||
| Oleanolic acid and ursolic acid induce apoptosis in four human liver cancer cell lines | Q39764144 | ||
| Celastrol inhibits production of nitric oxide and proinflammatory cytokines through MAPK signal transduction and NF-kappaB in LPS-stimulated BV-2 microglial cells | Q40030520 | ||
| Betulinic acid, a catalytic inhibitor of topoisomerase I, inhibits reactive oxygen species-mediated apoptotic topoisomerase I-DNA cleavable complex formation in prostate cancer cells but does not affect the process of cell death | Q40033563 | ||
| Effects of advanced glycation end product modification on proximal tubule epithelial cell processing of albumin | Q40077089 | ||
| Oxidative stress hypothesis in Alzheimer's disease | Q41482152 | ||
| Anti-inflammatory actions of pentacyclic triterpenes | Q41684947 | ||
| Asiatic acid and corosolic acid enhance the susceptibility of Pseudomonas aeruginosa biofilms to tobramycin | Q42045619 | ||
| Anti-glycative and anti-inflammatory effects of protocatechuic acid in brain of mice treated by D-galactose | Q42717600 | ||
| Ursolic acid attenuates D-galactose-induced inflammatory response in mouse prefrontal cortex through inhibiting AGEs/RAGE/NF-κB pathway activation. | Q43172749 | ||
| Disparate effects on renal and oxidative parameters following RAGE deletion, AGE accumulation inhibition, or dietary AGE control in experimental diabetic nephropathy. | Q43218267 | ||
| Anti-glycative effects of oleanolic acid and ursolic acid in kidney of diabetic mice | Q43241229 | ||
| Inhibitory effects of ursolic acid on hepatic polyol pathway and glucose production in streptozotocin-induced diabetic mice | Q43257383 | ||
| Astragalosides isolated from the root of astragalus radix inhibit the formation of advanced glycation end products | Q43291879 | ||
| Phase I clinical studies of the advanced glycation end-product (AGE)-breaker TRC4186: safety, tolerability and pharmacokinetics in healthy subjects | Q43296477 | ||
| In vitro and in vivo inhibitory activities of four Indian medicinal plant extracts and their major components on rat aldose reductase and generation of advanced glycation endproducts | Q43466937 | ||
| Active glycation in neurofibrillary pathology of Alzheimer disease: N(epsilon)-(carboxymethyl) lysine and hexitol-lysine | Q43664495 | ||
| Advanced glycosylation end products in patients with diabetic nephropathy | Q44031994 | ||
| Activation of tubular epithelial cells in diabetic nephropathy | Q44230963 | ||
| Pentosidine and N(epsilon)-(carboxymethyl)-lysine in Alzheimer's disease and vascular dementia | Q44260190 | ||
| Broncho-vasodilatory activity of fractions and pure constituents isolated from Bacopa monniera | Q44397711 | ||
| Regulation of cyclooxygenase-2 expression in monocytes by ligation of the receptor for advanced glycation end products | Q44499434 | ||
| Methylglyoxal induces oxidative stress-dependent cell injury and up-regulation of interleukin-1beta and nerve growth factor in cultured hippocampal neuronal cells | Q44820165 | ||
| Alternative routes for the formation of glyceraldehyde-derived AGEs (TAGE) in vivo | Q45003171 | ||
| Potential vasorelaxant effects of oleanolic acid and erythrodiol, two triterpenoids contained in 'orujo' olive oil, on rat aorta | Q45135732 | ||
| Anti-lipase and lipolytic activities of ursolic acid isolated from the roots of Actinidia arguta. | Q45916277 | ||
| Oxidative stress damage and oxidative stress responses in the choroid plexus in Alzheimer's disease. | Q45929819 | ||
| Advanced glycation end products regulate extracellular matrix protein and protease expression by human glomerular mesangial cells. | Q46087617 | ||
| Anti-oxidative and anti-inflammatory activities of some isolated constituents from the stem bark of Allanblackia monticola Staner L.C (Guttiferae). | Q46173052 | ||
| Oxidative stress mediates protein kinase C activation and advanced glycation end product formation in a mesangial cell model of diabetes and high protein diet | Q46379191 | ||
| Anti-inflammatory and antitumor-promoting effects of the triterpene acids from the leaves of Eriobotrya japonica | Q46736034 | ||
| Aldose-reductase- and protein-glycation-inhibitory principles from the whole plant of Duchesnea chrysantha | Q46738902 | ||
| Role of lupeol and lupeol linoleate on lipemic-oxidative stress in experimental hypercholesterolemia | Q46745151 | ||
| Protective effects of maslinic acid against alcohol-induced acute liver injury in mice | Q46827352 | ||
| Asiatic acid ameliorates hepatic lipid accumulation and insulin resistance in mice consuming a high-fat diet | Q46900078 | ||
| Glycyrrhizic acid attenuated glycative stress in kidney of diabetic mice through enhancing glyoxalase pathway | Q46925426 | ||
| Protection against carbon tetrachloride hepatotoxicity by oleanolic acid is not mediated through metallothionein | Q47945656 | ||
| Evidence against increased glycoxidation in patients with Alzheimer's disease | Q48635447 | ||
| Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism. | Q53348339 | ||
| Chemical modification of proteins by methylglyoxal | Q77659598 | ||
| Plasma protein advanced glycation end products, carboxymethyl cysteine, and carboxyethyl cysteine, are elevated and related to nephropathy in patients with diabetes | Q79821667 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 13 | |
| P577 | publication date | 2015-08-11 | |
| P1433 | published in | BioMedicine | Q27725996 |
| P1476 | title | Inhibitory effects and actions of pentacyclic triterpenes upon glycation | |
| P478 | volume | 5 |
| Q47164633 | Head and neck cancer associated with increased rate of pulmonary tuberculosis in a population-based cohort study |
| Q37654570 | Lupane-type triterpenes and their anti-cancer activities against most common malignant tumors: A review. |
| Q46780181 | Metformin Use Correlates with Reduced Risk of Gallstones in Diabetic Patients: A 12-Year Follow-up Study |
| Q41288601 | Oleanolic Acid Promotes Neuronal Differentiation and Histone Deacetylase 5 Phosphorylation in Rat Hippocampal Neurons |
| Q58764682 | Pharmacological Properties, Molecular Mechanisms, and Pharmaceutical Development of Asiatic Acid: A Pentacyclic Triterpenoid of Therapeutic Promise |
| Q38682777 | Statin use correlates with reduced risk of chronic osteomyelitis: a nationwide case-control study in Taiwan |
Search more.